Punters pile into Red Metal in oversubscribed share plan

Maronan raised $3.368 million against a target of $1.5 million in June, with a common denominator being Rob Rutherford, who is a non-executive director of the silver junior.

Other recent examples extend to Neurizon Therapeutics, a neurodegenerative medical company taking the fight to…